| Cindy E Hall, CRNA | |
|
1710 Harrison St, Batesville, AR 72501-7303 | |
| (870) 262-1200 | |
| Not Available |
| Full Name | Cindy E Hall |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 19 Years |
| Location | 1710 Harrison St, Batesville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356396931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 2007033988 (Missouri) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | C001533 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baxter Regional Medical Center | Mountain home, AR | Hospital |
| White River Medical Center | Batesville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arkansas Anesthesia Associates Pllc | 6406023142 | 56 |
| White River Health System Inc | 0143134270 | 150 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427149814 PECOS PAC ID: 0143134270 Enrollment ID: O20050406001290 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
| Entity Name | Baxter County Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114178753 PECOS PAC ID: 0042389264 Enrollment ID: O20081212000269 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477523348 PECOS PAC ID: 0143134270 Enrollment ID: O20110510000339 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
| Entity Name | Arkansas Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497023360 PECOS PAC ID: 6406023142 Enrollment ID: O20120119000835 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
| Entity Name | Mountain Home Surgery Center |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1205978780 PECOS PAC ID: 0345479655 Enrollment ID: O20140208000073 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cindy E Hall, CRNA 16 Hospital Cir Ste A, Batesville, AR 72501-7343 Ph: (870) 262-5545 | Cindy E Hall, CRNA 1710 Harrison St, Batesville, AR 72501-7303 Ph: (870) 262-1200 |
News Archive
Vapers across the country are swarming Twitter, the White House comment line and statehouse steps with the message "We Vape, We Vote."
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
CSL Behring announced today that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra, Immune Globulin Subcutaneous, 20% Liquid, from 24 months to 30 months.
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
› Verified 9 days ago
Mr. Richard Alan Alberti, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6063 | |
Adam B Hogue, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1286 Fax: 870-262-6063 | |
Mr. Steven Clay Chaffin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6063 | |
Mrs. Karen Diane Walls, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6063 | |
Mr. David Ross Cox, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6063 | |
Charles O Vaugier, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 | |
Zelda R. Epperson-may, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1235 Fax: 870-262-3170 |